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Rabies virus is a highly neurotropic virus that can cause fatal infection of the central nervous system in
warm-blooded animals. The RABV phosphoprotein (P), an essential cofactor of the virus RNA-dependent
RNA polymerase, is required for virus replication. In this study, the ribosomal protein L9, which has
functions in protein translation, is identiﬁed as P-interacting cellular factor using phage display analysis.
Direct binding between the L9 and P was conﬁrmed by protein pull-down and co-immunoprecipitation
analyses. It was further demonstrated that L9 translocates from the nucleus to the cytoplasm, where it
colocalizes with P in cells infected with RABV or transfected with P gene. RABV replication was reduced
with L9 overexpression and enhanced with L9 knockdown. Thus, we propose that during RABV infection,
P binds to L9 that translocates from the nucleus to the cytoplasm, inhibiting the initial stage of RABV
transcription.
& 2015 Elsevier Inc. All rights reserved.Introduction
Rabies, caused by rabies virus (RABV), remains a global public
health problem with approximately 59,000 human deaths
annually (McCarthy, 2015). RABV, a member of the family Rhab-
doviridae, is a non-segmented negative-strand RNA virus. (Ray
et al., 1995). The genome of RABV encodes ﬁve viral proteins,
including the nucleoprotein (N), phosphoprotein (P), matrix pro-
tein (M), glycoprotein (G), and large RNA-dependent RNA poly-
merase (L or RdRp) (Jackson, 2002). The N, P, and L of RABV par-
ticipate in viral transcription and replication in a regulated and
efﬁcient manner (Fu et al., 1994; Mavrakis et al., 2006).
P is a phosphorylated protein and consists of 297 amino acid
residues (Chenik et al., 1998). P is a nonenzymatic cofactor that
associates with the polymerase L and interacts with N to aid virallogy, College of Veterinary
ive, Athens, GA 30602, USA.
of Agricultural Microbiology,
l University, Wuhan 430070,replication (Chenik et al., 1994; Fu et al., 1994; Jacob et al., 2001).
The major L-binding site locates in the N-terminal 19 residues of P
(Chenik et al., 1998). P contains two N protein-binding domains:
one domain in the C-terminus (residues 268–297) binds to N-RNA,
and the other (residues 69–139) binds to N° (not bound to viral
RNA) (Chenik et al., 1994; Mavrakis et al., 2003, 2004).
P is also considered to be the primary interferon (IFN)
antagonist because of its capacity to bind signal transducer and
activator of transcription (STAT) proteins, which causes the nuclear
exclusion of the P-STAT complex via a strong export sequence
within P (Mavrakis et al., 2004; Pasdeloup et al., 2005; Vidy et al.,
2005; Wiltzer et al., 2014). In addition, P can interact with the
cytoplasmic dynein light chain (LC8), which is involved in the
retrograde axonal transport of RABV (Raux et al., 2000). RABV is
attenuated by simultaneously modifying the dynein light chain
binding site in P and replacing Arg333 in the glycoprotein
(Mebatsion, 2001). The P-LC8 interaction is not involved in viral
spread but in primary viral transcription (Tan et al., 2007).
The ribosomal protein L9 (rpL9 or L9) is a 192-amino-acid
protein and one of the ribosomal large subunit proteins (Wool
et al., 1995). L9 is essential for the translational function of the
ribosome and plays an important role in proper ribosome forma-
tion (Beyer et al., 2013) . In addition, L9 can interact with the
mouse mammary tumor virus (MMTV) Gag protein in cells
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et al., 2013) .
In this study, we demonstrated that P could bind directly to L9
both in vitro and in vivo. This interaction between P and L9 has a
biological effect on RABV replication.Results
Screening of P-interacting cellular partners
To screen cellular proteins that interact with P, His-tagged P
was expressed and puriﬁed. Using a phage display method, a
human brain cDNA library was screened with puriﬁed P as the
bait. Several P-interacting candidate proteins were identiﬁed
(Table 1), such as RPL9, KH domain, NEF-E, coiled-coil domain-
containing 12, ATP-binding cassette A, splicing factor 45, and
proline-rich nuclear receptor coactivator 2. Among the identiﬁed
cellular factors, we were particularly interested in viral replication-
related proteins. Considering the important role of L9 in mouse
mammary tumor virus (MMTV) assembly, we decided to focus on
investigating the potential role of L9 in RABV replication.
P binds to L9 both in vitro and in vivo
The binding of P to L9 in vitro was determined by GST pull-
down assay. The puriﬁed GST-tagged L9 (or GST) and His-tagged P
were co-incubated with glutathione agarose beads, and the bound
proteins were eluted with elution buffer, separated by SDS-PAGE,
and subjected to Western blotting with an anti-His antibody. The
results indicate that GST-L9 can pull down P (Fig. 1A). To examine
whether P interacts with L9 in the context of RABV infection, GST-
L9 was immobilized on glutathione agarose beads. Virus-infected
or uninfected 293T cell lysates were used in the GST pull-downTable 1
Phage display-screened cellular factors interacting with the P protein.
No Name Size (bp) Function
1 Ribosomal protein L9 579 60S ribosomal compositio
2 Negative-elongation factor E 1143 Participates with RNA pol
3 Coiled coil domain 12 540 Upstream transport along
4 ATP-binding cassette A 4746 Belong to ABC superfamil
particles; causes adrenal a
5 KH domain 1038 Transcribed within the nu
6 Splicing factor 45 1206 Combined with single 3 'A
7 Proline-rich nuclear receptor coactivator 2 420 A new type of nuclear rec
Fig. 1. Identiﬁcation of the interaction between P and L9 in vivo and vitro. (A) Identiﬁ
tagged L9 (or GST) and His-tagged P were co-incubated with glutathione agarose beads
proteins were subjected toWestern blotting with an anti-His antibody (bottom panel). La
GST. (B) Detection of P and L9 protein interaction in vivo. GST-tagged L9 (or GST) was
resolved by SDS-PAGE, and the rest were incubated with the 293T cell lysate of RABV-inf
infected cell lysate treated with GST-L9-bound agarose beads; lane 2, RABV-infected cell
in 293T cells by in vivo immunoprecipitation. 293T cells were co-transfected with pcDN
agarose, and proteins were detected by Western blotting with an anti-V5 antibody. Lanassay and probed for the presence of P. GST-L9 could pull down P
speciﬁcally from the RABV-infected cells (Fig. 1B). To further
conﬁrm P binding to the L9 protein in vivo, immunoprecipitation
analysis was performed. Here, 293T cells were co-transfected with
the plasmids pcDNA3.1-P-Fc and pcDNA3.1-L9-V5, expressing Fc-
tagged P and V5-tagged L9 protein, respectively. The protein
extracts obtained as a result of co-transfection of plasmids were
immunoprecipitated with protein A/G agarose and detected by
Western blotting with a V5-tag antibody. The results reveal that L9
is co-immunoprecipitated with P (Fig. 1C).
The central domain of P is essential for its binding to L9
The sequence of P required for its binding to L9 was determined
using a protein pull-down assay. GST-L9 was generated and
immobilized on glutathione agarose beads. His-tagged full-length
or truncations of P (P19–297, P52–297, P82–297, P138–297, P172–297, P1–
137, P1–180, and P1–218) were prepared (Fig. 2A) and used in the
protein pull-down analysis. The results indicate that GST-L9 can
speciﬁcally pull down P, and the central domain (residues 138–
180) of P is crucial for its binding with L9 (Fig. 2B). To further
conﬁrm the binding site, the P△138–180 protein with the central
domain (residues 138–180) deleted was constructed and analyzed
using the pull-down assay (Fig. 3C). As expected, the P△138–180
protein could not pull down the L9 protein (Fig. 3D).
The N terminal 39 residues of L9 are not involved in the interaction
with P
We used a similar strategy to investigate the sequence of L9
required for its binding to P. A full-length His-tagged P was gen-
erated and immobilized on nickel-nitrilotriacetic acid agar-
ose beads. The full-length GST-tagged L9 and truncated L9 (L91–39,
L91–61, L91–85, L962–192, L986–192, and L997–192) (Fig. 3A) weren, protein translation correction role, pseudogenes
ymerase II, role in the negative regulation of translation
neuronal axons, related to nutrient transport and signal transduction
y, is a key mediator of cholesterol and phospholipid efﬂux to apolipoprotein
nd brain protein malnutrition
cleic acid-binding protein, responsible for RNA identiﬁcation
G, exon and intron catalytic reactions and splicing
eptor regulatory protein, may be involved in nonsense-mediated mRNA decay
cation of the protein-protein interactions by GST pull-down in vitro. Puriﬁed GST-
. P (top panel) and L9 (middle panel) were detected by SDS-PAGE, and the bound
ne 1, P-His protein only; lane 2, P-His protein plus GST; lane 3, P-His protein plus L9-
bound to GST agarose beads. Some of the proteins isolated using the beads were
ected cells and detected by Western blotting with an anti-P antibody. Lane 1, RABV-
lysate treated with GST-bound agarose beads. (C) Detection of P and L9 interactions
A-P-Fc and pCDNA-L9-V5, immunoprecipitation was performed with protein A/G
e 1, P-Fc protein plus L9-V5; lane 2, Fc protein plus L9-V5; lane 3, P-Fc alone.
Fig. 2. Identiﬁcation of the essential domain of P binding with L9 by GST pull-down assay. (A) A schematic representation of P truncation. The numbers indicate the amino
acid positions of P. (B) Functional analysis of P binding to L9 by GST pull-down assay. Puriﬁed GST-tagged L9 (or GST) and His-tagged truncated P were co-incubated with
glutathione agarose beads. L9-GST(or GST) (top panel) and P truncated proteins (middle panel) were detected by SDS-PAGE, and the bound proteins were subjected to
Western blotting with an anti-His antibody (bottom panel). Lane 1 represents P plus GST; lanes 2, 3, 4, 5, 6, 7, 8, 9 and 10 represent P, P19–297, P52–297, P82–297, P138–297, P172–297,
P1–137, P1–180 and P1–218 plus L9, respectively. (C) Schematic representation of P with the deletion of residues 138–180; (D) A further determination of the interaction between
P△138–180 and L9 by His-pull-down. Lane 1, GST plus His-tagged P△138–180; lane 2, GST-tagged L9 plus His-tagged P△138–180; lane 3, GST-tagged L9 plus His-tagged P.
Fig. 3. Identiﬁcation of the essential domain of L9 protein binding with P by His
pull-down assay. (A) A schematic representation of the L9 protein deletions and
fusion proteins. The numbers indicate the amino acid positions of the L9 protein.
(B) Functional analysis of L9 binding to P by pull-down assay. Puriﬁed GST-tagged
truncated L9 (or GST) and His-tagged P were co-incubated with His-bound
sepharose beads. P was detected by SDS-PAGE (top panel), the bound proteins and
L9 truncated proteins were subjected to Western blotting with an anti-GST anti-
body (middle panel and bottom panel). Lanes 1, 2, 3, 4, 5, 6 and 7 represent L91–39,
L91–61, L91–85, L962–192, L986–192, L997–192 and L9 plus P, respectively.
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Fig. 3B, P could pull down both the full-length L9 and the C ter-
minus of L9, suggesting that the N terminus of L9 (residues 1–39)
is not involved in the interaction with P (Fig. 3B).
P stimulates the translocation of L9 from the nucleus to the cytoplasm
To investigate the cellular localizations of P and L9, 293T cells
were transfected with plasmids expressing EGFP-P or DsRed-L9
fusion proteins. The fusion protein localizations in cells were
directly observed by LSCM. DsRed-L9 was mainly localized in the
nucleus (Fig. 4A), whereas EGFP-P was uniformly distributed in the
cytoplasm (Fig. 4B).
The biological interaction between P and L9 was determined by
examining the co-localization of the two proteins. The plasmids
expressing the EGFP-P or DsRed-L9 fusion proteins were co-
transfected into 293T cells. The localizations of the fusion pro-
teins were detected by LSCM. More DsRed-L9 protein was
observed in the cytoplasm co-localizing with the EGFP-P rather
than distributed in the nucleus (Fig. 4C), indicating that P co-
localization with L9 resulted in the translocation of L9 from the
nucleus to the cytoplasm. The effects of P on the cellular dis-
tribution of L9 were further conﬁrmed in RABV-infected cells. As
shown in Fig. 4D, L9 mainly co-localized with P in the cytoplasm of
RABV-infected cells.
L9 overexpression reduces RABV replication
Finding that L9 can interact with P in the cytoplasm raised the
possibility that L9 could play a role in virus production. To test this
idea, 293T cells were infected with rAAV-L9 to overexpress L9 and
were subsequently infected with RABV-Rluc. In these cells, RABV
replication was decreased signiﬁcantly. Meanwhile, 293T cells
were infected with rAAV-GFP to overexpress GFP and then infec-
ted with RABV-Rluc as the control. The luciferase activity in L9-
overexpressing cells was reduced nearly 10–20-fold for different
doses of RABV-Rluc infection compared with the control (i.e., MOIs
of 101–104) (Fig. 5A). This result was conﬁrmed by Western blot
analysis performed from the lysates of these infected cells. P
expression in these two cell lines was observed and indicated that
Fig. 4. Identiﬁcation of the subcellular distribution and colocalization of the L9 and P (A and B). 293T cells were transfected with pDsRed-L9 or pEGFP-P individually. The
distributions of the fusion proteins DsRed-L9 (A) and GFP-P (B) were examined using confocal LSCM. (C) pDsRed-L9 and pEGFP-P were cotransfected into 293T cells. The
colocalization of the fusion proteins GFP-P with DsRed-L9 was detected using a confocal LSCM. (D) To investigate the colocalization of P and L9 in RABV-infected 293T cells,
anti-P and anti-L9 antibodies were used as primary antibodies, and FITC-labeled anti-mouse IgG antibody and tetramethyl rhodamine isothiocyanate-labeled anti-rabbit IgG
antibody were used as the respective secondary antibodies. The two proteins were detected using a confocal LSCM. To show the location of the nuclei, the cells were stained
with DAPI. Scale bar, 10 μm.
Y. Li et al. / Virology 488 (2016) 216–224 219less viral proteins are expressed in L9-overexpressing cells
(Fig. 5B). Further, we examined RABV growth curves in SK-N-SH
cells to investigate the effect of overexpressing L9 on RABV repli-
cation. There was a 10-fold decrease in viral production from 36 to
48 h in the presence of overexpressed L9 (Fig. 5C). To determine
whether L9 inﬂuence on decreased viral replication was unique to
RABV, the growth curves of VSV in rAAV-L9 and rAAV-GFP-infected
cells were also determined. As shown in Fig. 5D, there was no
signiﬁcant change in virus production between L9-overexpressing
cells and GFP-overexpressing cells at 5, 10, 15, 20, 25 and 30 h. All
of the results above indicated that L9 interfered with RABV repli-
cation speciﬁcally via its binding to P.
The knockdown of L9 expression enhances RABV replication
To further conﬁrm that L9 plays a role in RABV replication, the
L9 gene was knocked down using an L9-speciﬁc siRNA. Speciﬁ-
cally, 293T cells were transfected with an L9-speciﬁc siRNA or a
scrambled siRNA and were then infected with RABV. The effect of
L9-siRNA treatment on L9 expression relative to the β-actinloading controls was evaluated by Western blotting and lucifer-
ase assay. The siRNA treatment reduced the L9 expression by
approximately 51% compared with the scrambled control siRNA
(Po0.05) (Fig. 6A). The virus yield from the cells treated with the
L9 siRNA was enhanced 4.84-fold, and P expression was enhanced
by approximately 61% (Fig. 6B and C).The initial transcription of RABV is affected by P-L9 interaction
To investigate which step of the viral cycle is affected by P-L9
interaction, RNA analysis in the presence of cycloheximide was
performed by qRT-PCR. The qRT-PCR results show that mRNA copy
numbers in L9-overexpressing cells were signiﬁcantly reduced
(31.2–65.4%) compared with the controls treated with or without
CHX from 6 to 24 h (Fig. 7A). As a control, the level of VSV N mRNA
was unaffected in L9-overexpressing cells treated with or without
CHX from 6 to 24 h (Fig. 7B). Overall, our results show that the
initial transcription of RABV is affected by P-L9 interaction.
Fig. 5. The effect of L9 overexpression on RABV yield. (A) To investigate the effect of overexpressing L9 on RABV replication, SK-N-SH cells were infected at an MOI of 0.1 with
rAAV-L9 and rAAV-GFP. After 12 h, the cells were infected with 10–1, 10–2, 10–3, 10–4, 10–5 and 10–6 MOI RABV-Rluc for 36 h. Then, the luciferase activities were examined
using a single luciferase assay system (Promega), with the error bars representing the means7standard errors of the mean (n¼5). One-way ANOVA and Student's t-test
were performed to compare the treatment groups; *, Po0.05, **, Po0.01. (B) To investigate the effect of overexpressed L9 on RABV replication, 293T cells were infected at an
MOI of 0.1 with rAAV-L9 and rAAV-GFP. After 12 h, the cells were infected with 101 MOI RABV-Rluc for 48 h. P and His-tagged L9 levels were determined by Western blot
using anti-P and anti-His antibodies, respectively. Lanes 1–3, rAAV-GFP plus RABV infection; lanes 4–6, rAAV-L9 plus RABV infection. (C) SK-N-SH cells were infected with
rAAV-L9 and rAAV-GFP at an MOI of 0.1. After 24 h, the cells were infected using 0.1 MOI RABV-GFP. Then, the viral titers were detected via a direct immunoﬂuorescent
method at 12, 24, 36, 48, 60 and 72 h, and the viral growth curves were generated using GraphPad 5. (D) To prove a speciﬁc effect of L9 on RABV, 293T cells were infected
with rAAV-L9 and rAAV-GFP. After 12 h, the cells were infected with VSV at an MOI of 0.1. Then, the viral titers were detected via a direct immunoﬂuorescent method at 5, 10,
15, 20, 25 and 30 h. The viral growth curves were generated using GraphPad 5.
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Rabies remains a public health threat, with more than 59,000
fatalities each year worldwide. P plays important roles in viral
replication and transcription by binding to the N and L viral pro-
teins. In addition, P can bind STATs to inhibit IFN production and to
evade the innate immunity (Brzozka et al., 2005; Vidy et al., 2005;
Wiltzer et al., 2014). P can also interact with LC8, which may be
relevant to minus-end-directed axonal transport (Tan et al., 2007).
As an essential cofactor of the virus RdRp, P may take part in
additional physiological processes (Marschalek et al., 2012). To
explore these additional functions of P, we used puriﬁed P as the
bait to identify its cellular targets using a phage display approach.
In our study, we identiﬁed 7 cellular factors that may interact with
P. One of the candidates, L9, is a component of the 60S ribosome
and has a role in protein translation correction (Ulrich Stelzl et al.,
2001; Nature Publishing Group). In addition, NEF-E interacts with
RNA polymerase II as a negative regulator of translation (Wu et al.,
2005), and KH is a nucleic acid-binding protein responsible for the
identiﬁcation of RNA (Valverde et al., 2008).
Previous studies have demonstrated that L9 plays an important
role in interacting with the Gag protein of MMTV and translocates
the Gag from the cytoplasm to nucleus, inﬂuences MMTV assem-
bly . We propose that the interaction between P and L9 may also
serve to modulate RABV replication.
In this study, the direct binding of P to L9 was identiﬁed using
several independent approaches, such as pull-down and co-immunoprecipitation analyses. All of the results were consistent,
demonstrating that P interacts directly with L9 both in vivo and
in vitro. Amino acids 138–180 of P, which constitute a disordered
domain, are important for the interaction with L9, as determined
by GST pull-down (Gerard et al., 2009). This domain also overlaps
the binding sites between P and the dynein protein LC8 or mito-
chondrial complex I (Kammouni et al., 2015; Raux et al., 2000).
One previous study showed that residues 1–19 of P are responsible
for its interaction with the RABV L and that two domains (residues
69–139 and 268–297) are responsible for its interaction with the
RABV N (Vidy et al., 2005) . In addition, the C-terminal residues
173–297 of P are responsible for its interaction with STAT1
(Brzozka et al., 2005). These ﬁndings are consistent with the
multi-functional characteristics of P as a cofactor.
In the present study, we also identiﬁed that the N terminal 39
residues of L9 are not involved in the interaction with P. The N-
terminal domain (residues 1–84) of L9 is responsible for binding
the r-protein in the ribosome, while a larger C-terminal domain
(residues 85–192) binds to RNA (23S/28S) (Adamski et al., 1996;
Horng et al., 2002). However, it is not yet known if the interaction
between P and L9 affects the binding afﬁnity of L9 and RNA. Fur-
ther studies are needed to investigate this possibility.
The cellular co-location of L9, P and their interactions in
mammalian cells were evaluated in this study. The two proteins
were over-expressed by transfecting plasmids individually in dif-
ferent cell lines. P localized in the cytoplasm, while L9 was dis-
tributed throughout the cell, though predominantly in the
Fig. 6. The effect of L9 depletion on RABV production. 293T cells were infected and treated with L9-speciﬁc or scrambled control siRNA, followed by infection with RABV (0.1
MOI). (A) The effect of L9-siRNA treatment on the L9 expression relative to the β-actin loading controls, with the error bars representing the means7standard deviations
(n¼5). Two-tailed Student’s t-tests were performed to compare the treatment groups; *, Po0.05. A representative Western blot is shown on the left, indicating a selective
reduction in L9 expression. (B) The effect of L9-siRNA treatment on the expression of P relative to the β-actin loading controls. (C) The effect of the L9-siRNA treatment on the
RABV yield relative to the scrambled siRNA treatment controls.
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present in the same cells, P could bind to and recruit L9 to the
cytoplasm and promote its reduced distribution in the nucleolus.
More interestingly, the same results were obtained using an
indirect immunoﬂuorescence assay in RABV-infected 293T cells. L9
distributed in the cytoplasm, co-localizing with P. These results
may indicate that P may play a role in the translocation of L9 from
the nucleus to the cytoplasm. It has been reported that some
viruses hijack host ribosomal proteins to facilitate their own
replication (Warner and McIntosh, 2009). For instance, the MMTV
Gag protein can interact with the L9 protein and contribute to itsassembly (Beyer et al., 2013) . Moreover, overexpression of the
ribosomal protein L4 could increase the expression of the MLV
Gag-Pol fusion protein (Beyer et al., 2013) . Ribosomal proteins S5
and S9 interact with the hepatitis C virus RNA internal ribosome
entry site for optimal translation of viral proteins (Monach et al.,
1995). Thus, we propose that RABV replication may be modulated
by the interaction between P and L9. Indeed, RABV replication was
signiﬁcantly reduced when the L9 protein was over-expressed, and
RABV replication was signiﬁcantly enhanced when the expression
of L9 was knocked down. This effect on RABV replication is speciﬁc
because such an effect was not observed in cells infected with VSV,
Fig. 7. The effect of L9 overexpression on the initial transcription of RABV. To
investigate which step of the viral cycle is affected by P-L9 interaction, 293T cells
were infected with rAAV-L9 or rAAV-GFP for 24 h and then infected with RABV or
VSV. CHX was added into cells at a ﬁnal concentration of 100 mg/ml 1 h before virus
infection. At 6, 12, and 24 h after virus infection, cells were harvested and subjected
to quantitative real-time PCR (qRT-PCR). (A) The effect of overexpressed L9 on
RABV mRNA production was determined by qRT-PCR when the cells were treated
with or without CHX at 6, 12 and 24 h. Two-tailed Student's t-tests were performed
to compare the treatment groups; **, Po0.01, ***, Po0.001. (B) As a control, the
effect of overexpressed L9 on VSV mRNA production was determined by qRT-PCR
when the cells treated with or without CHX at 6, 12 and 24 h. Two-tailed Student's
t-tests were performed to compare the treatment groups.
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plays multiple roles during the viral replication cycle (Gerard et al.,
2009). In the initial stages of viral infection, P and N form a
complex, which keeps N in a soluble and monomeric form and
prevents cellular RNA from binding N, thus preserving the N for
speciﬁcally encapsidating the viral RNA (Gerard et al., 2009;
Mavrakis et al., 2003). In addition, P acts as a cofactor of the L
protein in both the viral transcription and replication processes
(Qanungo et al., 2004; Wang et al., 2014). L performs all of the
enzymatic activities but is unable to bind to viral nucleocapsids. P
binds to both nucleocapsids and L, which allows the association of
the polymerase with its template (Mavrakis et al., 2003). Thus, L9
may disturb the function of P as a viral noncatalytic cofactor and
may thereby modulate RABV replication.
Previous studies have shown that host molecules can modulate
the transcriptional activity of a viral polymerase. For example, heat
shock protein 72 can interact with the nucleoprotein of measles
viruses (Zhang et al., 2005), enhance viral polymerase efﬁciency,
and subsequently increase mortality in mice (Carsillo et al., 2006).The dynein light chain (LC8) was shown to interact with RABV P
(Raux et al., 2000), and involved in primary viral transcription (Tan
et al., 2007). Likewise, it is possible that L9 may also regulate the
efﬁciency of the RABV viral polymerase complex in a mechanism
that has yet to be deﬁned.
.Based on our results, we propose a model of the effect of L9 on
RABV replication. In the initial stage of RABV infection, L9 interacts
with the P protein and may disturb the function of P as a viral
noncatalytic cofactor, decreasing but not completely blocking RABV
transcription. As the infection progresses, more and more P protein
is expressed, while the amount of L9 is not signiﬁcantly altered.
Then, superﬂuous P protein can participate in viral replication at a
later stage. It partially explains why RABV infectious cycle is very
slow when compared with that of VSV, which helps RABV to escape
the immune responses. In summary, we demonstrate that P can
bind directly to L9 and can translocate L9 from the nucleus to the
cytoplasm, which inhibit the initial stages of RABV transcription.
This study serves as a reference for future studies aiming to
understand the function of P and its potential as a new drug target.Materials and methods
Cell culture and virus propagation
HEK-293T and human neuroblastoma cells (SK-N-SH) cells
were maintained in RPMI 1640 and Minimum essential medium
(MEM) containing 10% heat-inactivated fetal bovine serum (FBS).
In general, the adherent cells were infected with RABV or vesicular
stomatitis virus (VSV) at a multiplicity of infection (MOI) of 0.1 in
1640 or DMEM containing 2% FBS and were then incubated for 2 to
4 days. The RABV (SAD-L16 strain), RABV-Rluc (recombinant SAD-
L16 strain expressing Renilla luciferase reporter) and RABV-GFP
strains (recombinant SAD-L16 expressing EGFP) were stored at
80 °C, and VSV-GFP (recombinant VSV expressing GFP) was a gift
from Dr. Mingzhou Chen of Wuhan University.
Plasmid construction
P gene of RABV (SAD-L16) was ampliﬁed from P helper plasmid
used in the reverse genetic system (Zhao et al., 2009). The PCR
product was cloned into pET-42b with a C-terminal His6 tag to
yield the plasmid pET42b-P. P-truncated variants used in this
study were designed according to previous studies (Blondel et al.,
2002) and cloned into pET-42b with a C-terminal His6 tag to yield
the plasmids pET42b-P19–297, pET42b-P52–297, pET42b-P82–297,
pET42b-P138–297, pET42b-P172–297, pET42b-P1–137, pET42b-P1–180,
and pET42b-P1–218. To generate pEGFP-P, P gene was ampliﬁed
from PET42b-P, and the PCR product then was cloned into pEGFP-
N1. To yield the plasmids pcDNA3.1-P and pcDNA3.1-P-Fc, P gene
was ampliﬁed from PET42b-P, and the PCR products were cloned
into pcDNA3.1 and pcDNA3.1-Fc. To generate pET42b-P△138–180, the
P△180–297 gene with homologous arms was ampliﬁed from pET42b-
P, and the PCR product was recombined into PET42b-P1–137.
The L9 gene was ampliﬁed from a selected T7 phage cDNA bank
by PCR and then cloned into the pGEX-KG vector to yield the
plasmid pGEX-KG-L9, which could express the fusion protein GST-
L9. All of the L9-truncated variants, pGEX-KG-L91–39, pGEX-KG-
L91–61, pGEX-KG-L91–85, pGEX-KG-L962–192, pGEX-KG-L986–192, and
pGEX-KG-L997–192, were designed according to previous studies
(Beyer et al., 2013; Hoffman et al., 1994) and constructed on the
basis of plasmid pGEX-KG-L9. To generate pDsRed-L9, pcDNA3.1-
L9-V5, and pAAV-CMV-L9, the L9 gene was ampliﬁed from pGEX-
KG-L9 and then inserted into pDsRed-N1, pcDNA3.1-V5 and pAAV-
CMV, respectively.
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P or its mutants were expressed and puriﬁed as described
previously (Peng et al., 2008). Brieﬂy, the plasmid pET42b-P, fused
in frame with a C-terminal His6 tag, was transformed into
Escherichia coli BL21, and protein expression was induced with
0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3 h at
37 °C. After the incubation, cells were centrifuged and lysed fol-
lowed by centrifuging for 45 min at 8500 rpm and 4 °C. The pro-
tein in the supernatant was puriﬁed sequentially by nickel-
nitrilotriacetic acid (GE Healthcare, Uppsala, Sweden) and gel-
ﬁltration columns. All of the other truncations of P were expressed
and puriﬁed using the same approach. The L9 and L9-truncated
fragments were fused with an N-terminal glutathione S-
transferase (GST) tag and expressed using the same strategy as P.
A GST Trap HP column (GE Healthcare, Uppsala, Sweden) and a
Superdex 200 pg gel ﬁltration column were used for L9
puriﬁcation.
T7 select biopanning
A premade human brain cDNA library (No. 70550-3, Novagen)
was screened with the T7 Select biopanning kit (Novagen) accord-
ing to the manufacturer's instructions. The puriﬁed P was used as
the bait. After ﬁve rounds of selection, 236 randomly selected
clones were sequenced and blasted with known sequences using
the online program (http://www.ncbi.nlm.nih.gov/BLAST).
Protein pull-down assays
The puriﬁed GST-tagged L9 (or GST) and His-tagged P (or His-
tagged P-truncated proteins) were co-incubated with glutathione
agarose beads. After washing, the bound proteins were eluted with
elution buffer, separated by sodium dodecyl sulfate gel electro-
phoresis (SDS-PAGE), and subjected to Western blotting with a
mouse anti-His monoclonal antibody (1:5000, Boster, Wuhan,
Hubei, China) and a horseradish peroxidase (HRP)-conjugated goat
anti-mouse IgG antibody (1:5000, Proteintech, Wuhan, Hubei,
China).
To examine whether P interacts with the L9 in the context of
RABV infection, the puriﬁed GST-tagged L9 and RABV-infected
293T cell lysate were co-incubated with glutathione agarose beads.
The bound proteins were separated by SDS-PAGE and detected by
Western blotting with HRP-conjugated anti-P mouse monoclonal
antibodies (1:8000).
To identify the essential domain of L9 for its interaction with P,
the puriﬁed His-tagged P and L9 truncated proteins were co-
incubated with nickel-nitrilotriacetic acid agarose beads. The
bound proteins were detected by SDS-PAGE and Western blotting
with rabbit anti-GST polyclonal antibodies (1:5000, Boster,
Wuhan, Hubei, China) and goat anti-rabbit HRP-conjugated IgG
antibody (1:5000, Proteintech, Wuhan, Hubei, China). All the
Western blottings were developed using a chemiluminescence
reagent (ECL, Beyotime, Shanghai, China) and visualized with the
G:Box Chemi XT4 (Syngene UK).
Co-immunoprecipitation assay
The 293T cells were co-transfected with pcDNA3.1-L9-V5 and
pcDNA3.1-P-Fc, which express a V5-tagged L9 and an Fc-tagged P,
respectively. After 48 h, the cells were lysed and centrifuged; the
supernatants were incubated with protein A/G-agarose beads
(Santa Cruz Biotechnology). After three washes with radio-
immunoprecipitation assay (RIPA) buffer, the proteins bound to
the beads were separated by SDS-PAGE. Then, Western blotting
analysis was performed with a mouse V5 tag antibody (1:5000,Proteintech, Wuhan, Hubei, China) and an HRP-conjugated goat
anti-mouse IgG antibody.
Laser-scanning confocal microscopy analysis
The recombinant plasmids pDsRed-L9 and pEGFP-P were co-
transfected into 293T cells that were cultured on cover slips in a 24-
well plate. After 30 h, the cells were ﬁxed with 4% paraformalde-
hyde for 15 min and then washed three times with PBS. The nuclei
were counterstained with 40,6-diamidino-2-phenylindole (DAPI) for
10 min, and the slides were washed three times with PBS. The
ﬂuorescence was detected using a Laser-scanning confocal micro-
scope (LSCM, FV1000 Fluo View; Olympus). Meanwhile, pDsRed-L9
and pEGFP-P were individually transfected into 293T cells to verify
the locations of L9 and P. To verify the locations of P and endo-
genous L9, 293T cells were infected with RABV for 30 h, ﬁxed with
4% paraformaldehyde and blocked with 5% skim milk. The cells
were incubated with a mouse anti-P monoclonal antibody in PBS
containing 5% skim milk and a rabbit anti-L9 polyclonal antibody
(1:300, Santa Cruz Biotechnology, Inc.) for 2 h at room temperature
(RT) and then washed three times with PBST. The cells were incu-
bated with a ﬂuorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG antibody (1:300, Invitrogen, Carlsbad, CA, USA) and a
tetramethyl rhodamine isothiocyanate-conjugated goat anti-rabbit
IgG antibody (1:300, Invitrogen, Carlsbad, CA, USA) for 1 h. The
ﬂuorescence was detected using LSCM.
L9 overexpression and virus yield assays
The 293T cells were co-transfected with the pAAV-CMV-L9 (or
pAAV-CMV-GFP), pHelper, and pAAV-DJ plasmids (Moshiri et al.,
2014). After 48 h, the cells were pelleted by centrifugation, and
rAAV-L9 and rAAV-GFP were prepared by freezing and thawing. To
investigate the effect of L9 overexpression on RABV replication, SK-
N-SH cells were infected with rAAV-L9 or rAAV-GFP at an MOI of
0.1. After 24 h, the cells were infected with RABV expressing the
Renilla luciferase reporter at 101–106 MOI for 36 h. Then, the
luciferase activities were detected using a single luciferase assay
system (Promega), and the results were analyzed by one-way
ANOAV using GraphPad Prism 5 (GraphPad Software, Inc. San
Diego, California, USA).
SK-N-SH cells were infected with rAAV-L9 or rAAV-GFP at an
MOI of 0.1. After 24 h, the cells were infected with RABV-GFP at
0.1 MOI. Then, the viral titers of RABV were detected using a direct
immunoﬂuorescence assay at 12, 24, 36, 48, 60 and 72 h, and the
viral growth curves were generated using GraphPad Prism 5. To
investigate whether the effect of L9 on viral replication is speciﬁc
for RABV, VSV-GFP was incubated at 0.1 MOI with 293T cells
previously infected with rAAV-L9 or rAAV-GFP. Then, the viral
titers of VSV were detected using a direct immunoﬂuorescence
assay at 5, 10, 15, 20, 25 and 30 h, and the viral growth curves were
generated using GraphPad Prism 5.
L9 siRNA-mediated knockdown and virus yield assays
For these assays, 293T cells were seeded in 35-mm dishes at a
density of 0.25106 cells/dish and then transfected with L9 siRNA
or scrambled control siRNA (GenePharma, Shanghai, China) using
Lipofectamine 2000 according to the manufacturer's instructions.
After 12 h, the cells were infected at an MOI of 0.1 with RABV-Rluc.
After 48 h, the luciferase activities were detected. Normalized
amounts were analyzed by Western blotting for L9 and P expres-
sion. Each experiment was replicated ﬁve times, and the statistical
analyses were performed using two-tailed Student's t-tests in
GraphPad Prism 5.
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293T cells were infected with rAAV-L9 or rAAV-GFP for 24 h and
then infected with RABV or VSV. CHX was purchased from Sigma (St.
Louis, Mo.) and added into cells at a ﬁnal concentration of 100 mg/ml
1 h before infection with RABV or VSV as described previously (Bou-
dinot et al., 2001). At 6, 12, and 24 h after virus infection, cells were
harvested and subjected to quantitative real-time PCR (qRT-PCR).
qRT-PCR
The absolute quantiﬁcation of mRNA was performed as
described previously (Yang et al., 2015). Brieﬂy, total RNA were
extracted from cells using the RNeasy kit from Qiagen. The cDNA
of viral mRNA was synthesized by AMV reverse transcriptase XL
(Takara) following the manufacturer's instructions using RABV
gene-speciﬁc primer RABV-NR (TCATCTGCCAGTGCTACGTC) and
VSV gene-speciﬁc primer VSV-NR (AGTAGATACAAAGGCAACCA),
respectively. qRT-PCR was then performed using primers RABV-NF
(GAGGAATTCTTCGGGAAAGG) and RABV-NR, or VSV-NF (GAA-
TAAACATCGGGAAAGCA) and VSV-NR, respectively. A standard
curve was generated from serially diluted RNA in vitro transcribed
from a plasmid expressing RABV N and VSV N and the copy
numbers of RABV mRNA and VSV mRNA were normalized to 1 mg
of total RNA. The statistical analyses were performed using two-
tailed Student's t-tests in GraphPad Prism 5.Acknowledgments
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